Skip to main content Skip to section navigation Skip to footer
  • Visit us on Facebook
  • Visit us on Twitter
  • Visit us on Linkedin
Kintara Therapeutics, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Academic Collaboration
    • Advisors
  • Pipeline
    • Overview
    • REM-001
  • Clinical Trials
  • News & Media
    • Press Releases
    • Publications and Abstracts
    • Presentations
    • Recent News
    • Events
  • Investors
    • Overview
    • Analyst Coverage
    • News & Events
    • Company Info
    • Stock Info
    • SEC Filings
    • Governance
  • Contact
  • Careers

Recent News

News & Media

News & Media

  • Press Releases
  • Publications and Abstracts
  • Presentations
  • Recent News
  • Events

Targeted Oncology

Could VAL-083 Address Modest Treatment Efficacy in Glioblastoma?

August 24, 2023

Nature Medicine

Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

July 24, 2023

BioWorld

Other news to note for June 30, 2023

June 30, 2023

Conversations Life Science Leaders Aren't Having

The Path to Being and Becoming CEO - with Robert Hoffman

June 26, 2023

Drug Discovery World

Meet the Researcher: Dennis Brown, Kintara Therapeutics (Video Interview)

June 12, 2023

Outsourced Pharma

Small Molecules And The Arc Of Time

May 15, 2023

Outsourced Pharma

Large Balloons Over America, Small Molecules In China

May 8, 2023

Drug Discovery World

Eight announcements to expect at AACR 2023

April 20, 2023

Scrip Pharma Intelligence

Scrip Asks… What does 2023 Hold For Biopharma? Part 7: Clinical Trial Trends

February 28, 2023

CFO Dive

Biotech CFOs Sharpen Financing Tactics for Lean Times

January 18, 2023
rss_feed RSS
  • Page 1
  • Page 2
  • Next Pagearrow_forward
©2025 Kintara Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Legal Information Manage Cookie Preferences